Chiesi USA News and Activities

Chiesi USA is owned by Chiesi. Chiesi has a direct presence in 13 countries.

Chiesi has 15 subsidiaries including Amryt Pharma, Chiesi Central Eastern Europe and Chiesi Czech & Slovakia.

They are in:

• Pharmaceuticals94%
• Biotechnology6%

Acquisition, funding and merger involving Chiesi.

• Chiesi has announced the acquisition of Kalvista Pharmaceuticals  (posted on June 18 2026).
• Chiesi has acquired Kalvista Pharmaceuticals (posted on June 11 2026).

View the org chart displaying its 28 main executives

Most searched biographies at Chiesi USA

• Jon Zwinski, General Manager and Chief Executive Officer
• Debra Hussain, Vice President and Business Unit Leader of US Care
• John Hess, Head of Global Rare Diseases

Popular executive movements at Chiesi USA

• Debra Hussain has joined the company as Vice President and Business Unit Leader of US Care  (posted on May 13 2026).

Popular executive movements at Chiesi

• Maria Paola Chiesi, who was Vice Chairman of the Board, is promoted to Chairman of the Board  (posted on May 20 2026).
• Alessandro Chiesi who was Chairman of the Board, becomes Vice Chairman of the Board  (posted on May 20 2026).
• Jean-Marc Bellemin who is Executive Vice President Group, Chief Financial Officer, will become Interim Chief Executive Officer and Executive Vice President Group, Chief Financial Officer on May 6, 2026  (posted on April 24 2026).

Click here to view some more movements at Chiesi

Create your alert
to follow the executive moves at Chiesi USA.

Chiesi has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Chiesi USA

Social media about Chiesi USA

• Chiesi USA on Wikipedia, Google News & Yahoo Finance
• Chiesi USA on LinkedIn, X (Twitter) & YouTube